Sanofi’s SAR446523 Receives Orphan Drug Designation for Multiple Myeloma, Paving Way for Novel Treatment

Sanofi has announced a significant regulatory milestone for its investigational therapy SAR446523, a monoclonal antibody targeting GPRC5D, after the U.S. Food and Drug Administration (FDA) granted it orphan drug designation…

Continue Reading Sanofi’s SAR446523 Receives Orphan Drug Designation for Multiple Myeloma, Paving Way for Novel Treatment

Calidi Biotherapeutics’ CLD-201 Secures FDA Fast Track for Innovative Glioblastoma Therapy

Calidi Biotherapeutics has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Fast Track designation to its experimental therapy, CLD-201 SuperNova, for the treatment of glioblastoma.…

Continue Reading Calidi Biotherapeutics’ CLD-201 Secures FDA Fast Track for Innovative Glioblastoma Therapy

Illuminating Protein Dynamics: Novel Insights from High-Speed Atomic Force Microscopy

A recent research article in ScienceDirect.com details a breakthrough in visualizing the rapid, complex movements of proteins using high-speed atomic force microscopy (HS-AFM). This cutting-edge imaging technology allows scientists to…

Continue Reading Illuminating Protein Dynamics: Novel Insights from High-Speed Atomic Force Microscopy

Cure Rare Disease Expands Leadership Team to Accelerate Treatments for Ultra-Rare Conditions

Cure Rare Disease (CRD), a pioneering nonprofit biotechnology organization, has announced the addition of new scientific and strategic leaders, marking a significant step forward in its mission to develop therapies…

Continue Reading Cure Rare Disease Expands Leadership Team to Accelerate Treatments for Ultra-Rare Conditions

New European Project Aims to Improve Rare Disease Diagnosis and Care: Insights from the RARE-Impact Initiative

A recent article published in the Orphanet Journal of Rare Diseases highlights the launch and goals of RARE-Impact, a new European project designed to enhance the diagnosis, care, and overall…

Continue Reading New European Project Aims to Improve Rare Disease Diagnosis and Care: Insights from the RARE-Impact Initiative